Agidigbi TS, Kim C. Reactive oxygen species in Osteoclast differentiation and possible Pharmaceutical targets of ROS-Mediated Osteoclast diseases. Int J Mol Sci. 2019;20(14).

Baek JM, Kim JY, Yoon KH, Oh J, Lee MS. Ebselen is a potential Anti-osteoporosis Agent by suppressing receptor activator of nuclear factor Kappa-B ligand-Induced Osteoclast differentiation in vitro and Lipopolysaccharide-Induced Inflammatory Bone Destruction in vivo. Int J Biol Sci. 2016;12(5):478–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bennett RG, Duckworth WC, Hamel FG. Degradation of amylin by insulin-degrading enzyme. J Biol Chem. 2000;275(47):36621–5.

Article  CAS  PubMed  Google Scholar 

Chen K, Liu Y, He J, Pavlos N, Wang C, Kenny J, et al. Steroid-induced osteonecrosis of the femoral head reveals enhanced reactive oxygen species and hyperactive osteoclasts. Int J Biol Sci. 2020;16(11):1888–900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Cui Z, Wang Y, Lyu L, Feng C, Feng D, et al. Cyclic polypeptide D7 protects bone marrow mesenchymal cells and promotes chondrogenesis during osteonecrosis of the femoral head via growth differentiation factor 15-Mediated Redox Signaling. Oxid Med Cell Longev. 2022;2022:3182368.

PubMed  PubMed Central  Google Scholar 

Cheon YH, Lee CH, Jeong DH, Kwak SC, Kim S, Lee MS et al. Dual oxidase maturation factor 1 positively regulates RANKL-Induced Osteoclastogenesis via activating reactive oxygen species and TRAF6-Mediated signaling. Int J Mol Sci. 2020;21(17).

Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging. J Neuroinflammation. 2023;20(1):233.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Z, Feng C, Chen J, Wang Y, Meng Q, Zhao S, et al. Network Pharmacology deciphers the action of Bioactive Polypeptide in attenuating inflammatory Osteolysis via the Suppression of Oxidative Stress and restoration of bone remodeling balance. Oxid Med Cell Longev. 2022;2022:4913534.

Article  PubMed  PubMed Central  Google Scholar 

Drescher W, Varoga D, Liebs TR, Lohse J, Herdegen T, Hassenpflug J, et al. Femoral artery constriction by norepinephrine is enhanced by methylprednisolone in a rat model. J Bone Joint Surg Am. 2006;88(Suppl 3):162–6.

PubMed  Google Scholar 

González-Casimiro CM, Merino B, Casanueva-Álvarez E, Postigo-Casado T, Cámara-Torres P, Fernández-Díaz CM et al. Modulation of insulin sensitivity by insulin-degrading enzyme. Biomedicines. 2021;9(1).

Guo DY, Chen ZH, Fu YF, Li YY, Chen MN, Wu JJ, et al. Cilengitide inhibits osteoclast adhesion through blocking the α(v)β(3)-mediated FAK/Src signaling pathway. Heliyon. 2023;9(7):e17841.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guzman RA, Maruyama M, Moeinzadeh S, Lui E, Zhang N, Storaci HW, et al. The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbits. Stem Cell Res Ther. 2021;12(1):503.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han J, Yang K, An J, Jiang N, Fu S, Tang X. The role of NRF2 in bone metabolism - friend or foe? Front Endocrinol (Lausanne). 2022;13:813057.

Article  PubMed  Google Scholar 

Jackson EK, Mi E, Ritov VB, Gillespie DG. Extracellular ubiquitin(1–76) and ubiquitin(1–74) regulate Cardiac Fibroblast Proliferation. Hypertension. 2018;72(4):909–17.

Article  CAS  PubMed  Google Scholar 

Jia D, O’Brien CA, Stewart SA, Manolagas SC, Weinstein RS. Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology. 2006;147(12):5592–9.

Article  CAS  PubMed  Google Scholar 

Jiang H, Lin C, Cai T, Jiang L, Lou C, Lin S et al. Taxifolin-mediated Nrf2 activation ameliorates oxidative stress and apoptosis for the treatment of glucocorticoid-induced osteonecrosis of the femoral head. Phytother Res. 2023.

Jordá A, Aldasoro M, Campo-Palacio I, Vila JM, Aldasoro C, Campos-Campos J et al. Facilitation of insulin effects by Ranolazine in astrocytes in primary culture. Int J Mol Sci. 2022;23(19).

Kane AD, Herrera EA, Niu Y, Camm EJ, Allison BJ, Tijsseling D, et al. Combined statin and glucocorticoid therapy for the Safer treatment of Preterm Birth. Hypertension. 2023;80(4):837–51.

Article  CAS  PubMed  Google Scholar 

Kanzaki H, Shinohara F, Kajiya M, Kodama T. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling. J Biol Chem. 2013;288(32):23009–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol. 2009;114(3–5):121–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim SC, Gu DR, Yang H, Lee SJ, Ryuk JA, Ha H. Isolation and characterization of an anti-osteoporotic compound from Melia Toosendan Fructus. Pharmaceutics. 2023;15(10).

Kunig VBK, Potowski M, Klika Škopić M, Brunschweiger A. Scanning protein surfaces with DNA-Encoded libraries. ChemMedChem. 2021;16(7):1048–62.

Article  CAS  PubMed  Google Scholar 

Kupfer SR, Wilson EM, French FS. Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem. 1994;269(32):20622–8.

Article  CAS  PubMed  Google Scholar 

Leissring MA. Insulin-degrading enzyme: paradoxes and possibilities. Cells. 2021;10(9).

Leroux F, Bosc D, Beghyn T, Hermant P, Warenghem S, Landry V, et al. Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. Eur J Med Chem. 2019;179:557–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lesire L, Leroux F, Deprez-Poulain R, Deprez B. Insulin-degrading enzyme, an under-estimated potential target to treat Cancer? Cells. 2022;11(7).

Li ZQ, Li CH. CRISPR/Cas9 from bench to bedside: what clinicians need to know before application? Mil Med Res. 2020;7(1):61.

PubMed  PubMed Central  Google Scholar 

Li Q, Ali MA, Cohen JI. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell. 2006;127(2):305–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin X, Zhang K, Wei D, Tian Y, Gao Y, Chen Z et al. The impact of spaceflight and simulated microgravity on cell adhesion. Int J Mol Sci. 2020;21(9).

Liu Y, Loijens JC, Martin KH, Karginov AV, Parsons JT. The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell. 2002;13(6):2147–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Shan H, Zong Y, Lin Y, Xia W, Wang N, et al. IKKe in osteoclast inhibits the progression of methylprednisolone-induced osteonecrosis. Int J Biol Sci. 2021;17(5):1353–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Mo L, Lu H, Wei Y, Zhang J, Bennett S, et al. Dragon blood resin ameliorates steroid-induced osteonecrosis of femoral head through osteoclastic pathways. Front Cell Dev Biol. 2023;11:1202888.

Article  PubMed  PubMed Central  Google Scholar 

Ma J, Kitaura H, Ogawa S, Ohori F, Noguchi T, Marahleh A, et al. Docosahexaenoic acid inhibits TNF-α-induced osteoclast formation and orthodontic tooth movement through GPR120. Front Immunol. 2022;13:929690.

Article  CAS  PubMed  Google Scholar 

Maianti JP, McFedries A, Foda ZH, Kleiner RE, Du XQ, Leissring MA, et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature. 2014;511(7507):94–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng Q, Wang Y, Yuan T, Su Y, Li Z, Sun S. Osteoclast: the novel whistleblower in osteonecrosis of the femoral head. Gene Rep. 2023;33:101833.

Article  CAS  Google Scholar 

Merino B, Casanueva-Álvarez E, Quesada I, González-Casimiro CM, Fernández-Díaz CM, Postigo-Casado T, et al. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation. Diabetologia. 2022;65(8):1375–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mirsky IA, Broh-Kahn RH. The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts. Arch Biochem. 1949;20(1):1–9.